GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirona Biochem Corp (TSXV:SBM) » Definitions » EBITDA Margin %

Sirona Biochem (TSXV:SBM) EBITDA Margin % : -33,100.00% (As of Jan. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Sirona Biochem EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Sirona Biochem's EBITDA for the three months ended in Jan. 2024 was C$-0.66 Mil. Sirona Biochem's Revenue for the three months ended in Jan. 2024 was C$0.00 Mil. Therefore, Sirona Biochem's EBITDA margin for the quarter that ended in Jan. 2024 was -33,100.00%.


Sirona Biochem EBITDA Margin % Historical Data

The historical data trend for Sirona Biochem's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirona Biochem EBITDA Margin % Chart

Sirona Biochem Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3,263.97 -3,884.91 -857.84 -523.21 -6,665.71

Sirona Biochem Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -1,260.00 -6,457.14 1,581.25 -33,100.00

Competitive Comparison of Sirona Biochem's EBITDA Margin %

For the Biotechnology subindustry, Sirona Biochem's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sirona Biochem's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sirona Biochem's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Sirona Biochem's EBITDA Margin % falls into.



Sirona Biochem EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Sirona Biochem's EBITDA Margin % for the fiscal year that ended in Oct. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Oct. 2023 )/Revenue (A: Oct. 2023 )
=-2.333/0.035
=-6,665.71 %

Sirona Biochem's EBITDA Margin % for the quarter that ended in Jan. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Jan. 2024 )/Revenue (Q: Jan. 2024 )
=-0.662/0.002
=-33,100.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sirona Biochem  (TSXV:SBM) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Sirona Biochem EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Sirona Biochem's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sirona Biochem (TSXV:SBM) Business Description

Traded in Other Exchanges
Address
C/o WeWork, 595 Burrard Street, Vancouver, BC, CAN, V7X 1L3
Sirona Biochem Corp is a development stage biotechnology company. The principal activities of the company are the development of cosmetic and pharmaceutical active ingredients which are licensed to partners in exchange for upfront, milestone, and royalty payments. The company acts as a cosmetic ingredient and drug discovery company with a proprietary technology platform with a specialization in the stabilization of carbohydrate molecules. It has a business presence in Canada and France.
Executives
Howard Jarman Verrico Director, Senior Officer

Sirona Biochem (TSXV:SBM) Headlines